Evidence map›Paper›PMID 41324907›Full record

ArticleJCI insight2026

Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.

Philipp N Ostermann, Youjun Wu, Scott A Bowler, Samuel Martínez-Meza, Mohammad Adnan Siddiqui, David H Meyer, Alberto Herrera, Brandon A Sealy, Mega Sidharta, Kiran Ramnarine and 8 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Philipp N OstermannDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Youjun WuThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, New York, USA.
Scott A BowlerDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Samuel Martínez-MezaDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Mohammad Adnan SiddiquiAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
David H MeyerInstitute for Genome Stability in Aging and Disease, University Hospital and University of Cologne, Cologne, Germany.
Alberto HerreraDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Brandon A SealyInstitute of Translational Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Mega SidhartaThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, New York, USA.
Kiran RamnarineThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, New York, USA.
Leslie Ann St BernardDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Desiree ByrdDepartment of Neurology, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.
R Brad JonesDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Masahiro YamashitaAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Douglas F NixonDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Lishomwa C NdhlovuDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Ting ZhouThe SKI Stem Cell Research Facility, The Center for Stem Cell Biology and Developmental Biology Program, Sloan Kettering Institute, New York, New York, USA.
Teresa H EveringDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposureU01DA058527 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Michael Jay Corley, Lishomwa C Ndhlovu · 2023 to 2026
$9.4M
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistenceR01MH130197 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI Lishomwa C Ndhlovu, Afamefuna Okoye · 2022 to 2026
$5.1M
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuseand Aging on Cognitive ImpairmentR01DA052027 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI NDHLOVU, LISHOMWA C, NIXON, DOUGLAS F · 2020 to 2024
$3.7M
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral SuppressionR01NS117458 · NINDS · WISTAR INSTITUTE · PI ABDEL MOHSEN, MOHAMED, NDHLOVU, LISHOMWA C · 2020 to 2023
$3.4M
The Role of Transposable Elements in Healthy Aging and in Alzheimer's DiseaseR56AG078970 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI NIXON, DOUGLAS F · 2022 to 2022
$1.4M
A Precision Medicine Approach to Investigating the Molecular Impact of Age and Neurocognitive Impairment in People Living with HIV (PLWH)R21NS126094 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVERING, TERESA · 2021 to 2021
$557k
Single-Cell Analysis of HIV ReplicationR56AI125128 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI YAMASHITA, MASAHIRO · 2017 to 2017
$495k
Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1R21AG071433 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI EVERING, TERESA · 2021 to 2022
$489k
NCI NIH HHS P30 CA008748NIAID NIH HHS R56 AI125128NIAID NIH HHS UM1 AI164559NIA NIH HHS R21 AG071433NIA NIH HHS R56 AG078970NIDA NIH HHS R01 DA052027NIDA NIH HHS U01 DA058527NIMH NIH HHS R01 MH130197NINDS NIH HHS R01 NS117458NINDS NIH HHS R21 NS126094
6 · The paper itself

Abstract

Neurocognitive impairment is a prevalent comorbidity in virologically suppressed people living with HIV (PLWH), yet the underlying mechanisms remain elusive and treatments lacking. We explored use of participant-derived directly induced neurons (iNs) to model neuronal biology and injury in PLWH. iNs retain age- and disease-related donor features, providing unique opportunities to reveal important aspects of neurological disorders. We obtained primary dermal fibroblasts from 6 virologically suppressed PLWH and 7 matched people without HIV (PWOH). iNs were generated using transcription factors NGN2 and ASCL1 and validated by immunocytochemistry, single-cell RNA-Seq, and electrophysiological recordings. Transcriptomic aging analyses confirmed retention of donor age-related signatures. Bulk RNA-Seq identified 29 significantly differentially expressed genes between PLWH and PWOH iNs. Of these, 16 were downregulated and 13 upregulated in PLWH iNs. Protein-protein interaction network mapping indicated iNs from PLWH exhibited differences in extracellular matrix organization and synaptic transmission. IFI27 was upregulated in PLWH iNs, complementing independent postmortem studies demonstrating elevated IFI27 expression in PLWH-derived brain tissue. FOXL2NB-FOXL2-LINC01391 expression was reduced in PLWH iNs and negatively correlated with neurocognitive impairment. Thus, we identified an iN gene signature of HIV revealing mechanisms of neurocognitive impairment in PLWH.

Indexed as

HIV InfectionsNeuronsAdultBasic Helix-Loop-Helix ProteinsFemaleFibroblastsGene Expression ProfilingHumansMaleMiddle AgedNerve Tissue ProteinsTranscriptomeASCL1 protein, humanBasic Helix-Loop-Helix ProteinsNerve Tissue ProteinsNEUROG2 protein, humanAIDS/HIVNeurological disordersNeuroscience

Identifiers

PMID41324907
PMCPMC12892921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.